FDA recalls 13,500 bottles of blood pressure medication
If you have a bottle of chlorthalidone sitting in your medicine cabinet, you may want to check the label before taking your next dose. The FDA has recalled more than 13,500 bottles of chlorthalidone 25mg tablets after the medication failed dissolution specifications. This means the tablets did not meet the required standard for how they break down after being taken.
The recall, issued by Inventia Healthcare Limited, covers a specific batch of the medication distributed across the U.S.
Here is what to check
The affected medication comes in 100-count bottles with the NDC 64980-599-01, batch number RISA24002 and expiration date of April 2027. The FDA initially announced the recall on September 3 and classified it as a Class II recall on September 17.
While the classification sounds scary, Class II does not automatically mean the medication is dangerously toxic. The FDA uses the category when exposure to a problem product could cause temporary or medically reversible health effects, or when the risk of serious harm is considered remote.
What is chlorthalidone used for?
Chlorthalidone is a diuretic, commonly known as a water pill. According to the Mayo Clinic, it is used to treat high blood pressure and fluid retention associated with conditions such as congestive heart failure and certain liver or kidney diseases. Because it helps the body get rid of excess salt and water, it can play an important role in managing blood pressure and fluid buildup.
This is not the first time a chlorthalidone product has run into dissolution problems. In June, the FDA also recalled a chlorthalidone product distributed by Rising Pharma Holdings over failed dissolution specifications. For anyone taking chlorthalidone, the important part is not to panic but to check whether your bottle matches the recalled batch. If it does, contact your pharmacist or healthcare provider for guidance rather than simply stopping a prescribed blood pressure medication on your own.
Source: WSBTV
